LifeStance Health (LFST) Capital Expenditures (2020 - 2026)

LifeStance Health (LFST) has 7 years of Capital Expenditures data on file, last reported at $10.8 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $10.8 million, up 50.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.7 million (up 68.11% YoY), and the FY2025 annual result was $36.1 million, up 67.51% from the prior year.
• Capital Expenditures retreated to $10.8 million in Q1 2026 per LFST's latest filing, from $10.9 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $27.9 million in Q1 2022 and troughed at $5.1 million in Q3 2024.
• A 5-year average of $11.1 million and a median of $10.3 million in 2025 frame the typical range for Capital Expenditures.
• On a YoY basis, Capital Expenditures climbed as much as 151.87% in 2022 and fell as far as 73.15% in 2022.
• A 5-year view of Capital Expenditures shows it stood at $10.4 million in 2022, then rose by 9.92% to $11.4 million in 2023, then slumped by 44.8% to $6.3 million in 2024, then jumped by 73.16% to $10.9 million in 2025, then retreated by 1.32% to $10.8 million in 2026.
• Business Quant data shows LFST's Capital Expenditures at $10.8 million in Q1 2026, $10.9 million in Q4 2025, and $10.3 million in Q3 2025.